33 participants
Cabozantinib and Atezolizumab for the Treatment of Metastatic Castration-Resistant Prostate Cancer
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-06-05
- Start Date:
- 2022-03-29
- Completion:
- 2026-07-31
Conditions
- Castration-Resistant Prostate Carcinoma
- Metastatic Prostate Adenocarcinoma
- Stage IV Prostate Cancer AJCC v8
- Stage IVA Prostate Cancer AJCC v8
- Stage IVB Prostate Cancer AJCC v8
Interventions
- BIOLOGICAL
- DRUG
No Results Yet